China’s Abrupt Covid Pivot Leaves Many Without Medicines

Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.

#beijing-china, #biontech-se, #china, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #drugstores, #east-asia, #hong-kong, #hospitals, #ibuprofen-drug, #jinan-china, #pain-relieving-drugs, #paxlovid-drug, #pfizer-inc, #shanghai-china, #shortages

Study Shows New Covid Booster Improves Protection for Older People, Pfizer Says

Federal officials are hoping that the encouraging results will spur more Americans to get an updated booster before a feared surge in coronavirus cases this winter.

#biontech-se, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #pfizer-inc, #research, #united-states-politics-and-government, #vaccination-and-immunization

FDA Authorizes Updated Covid Booster Shots For Kids 5 to 11

Regulators authorized the shots for older age groups in late August, but much of the general population appears either unaware or uninterested in them.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

Moderna Sues Pfizer and BioNTech Over Covid Vaccine

The lawsuit, filed Friday, alleges that the companies’ Covid vaccine violated Moderna’s mRNA patents.

#bancel-stephane, #biontech-se, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #germany, #inventions-and-patents, #massachusetts, #moderna-inc, #pfizer-inc, #suits-and-litigation-civil, #vaccination-and-immunization

Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions

The vaccines seem safe for children and are likely to protect against severe illness. But data on efficacy are thin, and most children have already been infected.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #moderna-inc, #parenting, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

F.D.A. Authorizes Moderna and Pfizer Covid Vaccines for Youngest Children

A recommendation from the C.D.C. director would be the final step before doses are rolled out for the roughly 20 million children under the age of 5.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states, #vaccination-and-immunization

A Better Way to Measure Immunity in Children

Some scientists believe that a clearer picture of Covid vaccine efficacy could have emerged sooner if investigators had tracked certain immune cells, not just antibodies.

#antibodies, #biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #immune-system, #moderna-inc, #parenting, #pfizer-inc, #tests-medical, #vaccination-and-immunization, #your-feed-science

F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children

States have already ordered millions of doses; if the agency authorizes them in the coming days, babies, toddlers and preschoolers could start receiving shots next week.

#biontech-se, #centers-for-disease-control-and-prevention, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #vaccination-and-immunization, #walensky-rochelle

Pfizer Vaccine Effective in Children Under 5, the F.D.A. Says

Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest children.

#biontech-se, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #vaccination-and-immunization

C.D.C. Advisers Recommend Pfizer Boosters for Children 5 to 11.

A third dose would enhance immunity to the coronavirus, the agency said. But hesitancy is high, and less than one-third of children in this age group have received two doses.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #pfizer-inc, #united-states, #vaccination-and-immunization

The F.D.A. authorizes Pfizer-BioNTech boosters for children ages 5 to 11.

More than eight million of the 28 million children in that age group in the United States have received two vaccine shots.

#biontech-se, #coronavirus-2019-ncov, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

F.D.A. Expected to Soon Clear Pfizer Booster for Children Ages 5 to 11

Given that the age group has the lowest coronavirus vaccination rate of all eligible Americans, public health experts are not expecting a rush for the booster.

#biontech-se, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #pfizer-inc, #united-states, #vaccination-and-immunization

F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5

Both Moderna and Pfizer-BioNTech have asked the agency to approve their vaccines for the youngest children.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states, #vaccination-and-immunization

Pfizer Says Booster Strengthens Immune Response for Children 5 to 11

Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Older

People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies are also eligible.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

Biden Administration Likely to Offer Older Americans Second Booster Shots

Federal officials appear to be coalescing around a plan to offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again soon.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

Sinovac Booster Gives Elderly Stronger Protection Against Omicron, Study Finds

Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong.

#biontech-se, #china, #coronavirus-2019-ncov, #disease-rates, #hong-kong, #pfizer-inc, #research, #sinovac-biotech-ltd, #vaccination-and-immunization, #your-feed-healthcare

Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Children

The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic Covid-19.

#biontech-se, #centers-for-disease-control-and-prevention, #clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

Pfizer Seeks Authorization of a Second Booster Shot for Older Americans

The move could further inflame a tortuous debate among scientists over when the coronavirus vaccines’ protection should be bolstered, and for whom.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #elderly, #food-and-drug-administration, #national-institutes-of-health, #pfizer-inc, #research, #vaccination-and-immunization

The J.&J. Vaccine Holds Its Own as Virus Data Grows

Once dismissed as less effective, the vaccine now seems to be preventing infections and illness about as well as the two mRNA options.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #disease-rates, #johnsonjohnson, #moderna-inc, #pfizer-inc, #vaccination-and-immunization, #your-feed-science

Which Coronavirus Vaccine Will Work in the Youngest Children?

Moderna is going head-to-head with Pfizer-BioNTech for the opportunity to vaccinate the youngest children, the only Americans still not eligible for shots.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #research, #united-states, #vaccination-and-immunization

Why China Doesn’t Have an mRNA Vaccine for Covid

Beijing once said it had two mRNA shots within reach and ready for approval — one homemade and one produced by a foreign company. Today, neither are available.

#biontech-se, #china, #china-national-pharmaceutical-group-corp-sinopharm, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #shanghai-fosun-pharmaceutical-group, #sinovac-biotech-ltd, #vaccination-and-immunization

Will Adults Need a Fourth Dose of Covid Vaccine? It’s Too Soon to Know.

A Food and Drug Administration official said the best time for an additional shot may be fall, when the spread of the coronavirus is expected to pick up again

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #vaccination-and-immunization

Covid Vaccines for Kids Under 5: What Parents Should Know

Here’s what families should know about the delay.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-risks-and-safety-concerns, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

F.D.A Delays Review of Pfizer’s Covid Vaccine for Children Under 5

The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

The Next Vaccine Debate: Immunize Young Children Now, or Wait?

It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #immune-system, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

What’s Going on With Vaccines for Kids Under 5?

It’s confusing, but don’t freak out.

#biontech-se, #bronx-nyc, #coronavirus-2019-ncov, #internal-sub-only-nl, #kaiser-family-foundation, #parenting, #pfizer-inc, #twitter, #vaccination-and-immunization

Covid Vaccines Rarely Lead to Problems for Young Children, C.D.C. Reports

The reports, both released on Thursday, underscored the importance of vaccinating children against the coronavirus.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov

F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

Regulators will also allow even younger children with immune deficiencies to get an extra shot.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #teenagers-and-adolescence, #vaccination-and-immunization, #walensky-rochelle

Pfizer Says Its Booster Is Effective Against Omicron

The company’s finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.

#antibodies, #biontech-se, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #pfizer-inc, #vaccination-and-immunization

Pfizer says blood samples from people who got three of its doses show robust antibody levels against Omicron.

#antibodies, #biontech-se, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #pfizer-inc, #united-states, #vaccination-and-immunization

C.D.C. Endorses Covid Vaccine Booster Shots for All Adults

As infections rise, Americans over 18 will be permitted to get extra doses. But it’s not clear boosters really are needed by so many people, or that the shots will turn back the pandemic.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #coronavirus-delta-variant, #coronavirus-risks-and-safety-concerns, #disease-rates, #food-and-drug-administration, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week

Regulators are set to clear extra doses of Pfizer-BioNTech’s vaccine as soon as Thursday, after states began expanding eligibility on their own.

#biontech-se, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #regulation-and-deregulation-of-industry, #united-states-politics-and-government, #vaccination-and-immunization

Pfizer Asks F.D.A. to Expand Booster Eligibility to All Adults

In a turnaround, the agency is expected to grant the request before the winter holiday season, giving access to all 181 million fully vaccinated people.

#biontech-se, #coronavirus-2019-ncov, #food-and-drug-administration, #pfizer-inc, #regulation-and-deregulation-of-industry, #united-states-politics-and-government, #vaccination-and-immunization

How to Get a Covid Vaccine Shot for Your Kid

Every child 5 years and older is now eligible, but getting an appointment may take a little patience.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #parenting, #pfizer-inc, #vaccination-and-immunization

C.D.C. Recommends Covid Vaccine for Younger Children

With the agency director’s sign-off, children ages 5 to 11 could begin to receive the shots this week.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #disease-rates, #heart, #pediatric-inflammatory-multisystem-syndrome-pims, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

Covid-19 and Children: How Often Do Vaccines Cause Heart Problems?

The latest data is reassuring. Myocarditis remains very uncommon, and it is almost always mild and temporary. The heart risk from Covid-19 itself is far greater.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #food-and-drug-administration, #heart, #moderna-inc, #pfizer-inc, #teenagers-and-adolescence, #united-states, #vaccination-and-immunization, #your-feed-science

Are Vaccine Boosters Widely Needed? Some Federal Advisers Have Misgivings.

“In our hearts, I think people don’t quite agree with this notion of a booster dose,” said one leading vaccine expert.

#advisory-committee-on-immunization-practices, #biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #pfizer-inc, #vaccination-and-immunization, #your-feed-science

F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11

The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps as early as next week, a long-awaited development that would affect 28 million children.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

C.D.C. Recommends Covid Booster Shots for Millions of Americans

Recipients of the Moderna and the J.&J. vaccines may receive extra doses, although the shots continue to prevent illness and death.

#advisory-committee-on-immunization-practices, #biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #disease-rates, #immune-system, #johnsonjohnson, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization, #your-feed-science

F.D.A. Authorizes Moderna and Johnson & Johnson Booster Shots

The agency will also allow vaccine recipients to pick which vaccine they want as a booster, endorsing a mix-and-match approach.

#biontech-se, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

Where Things Stand on Boosters for Three Vaccines in the U.S.

Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard may help.

#biontech-se, #coronavirus-2019-ncov, #disease-rates, #drugs-pharmaceuticals, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #pfizer-inc, #regulation-and-deregulation-of-industry, #vaccination-and-immunization

As International Travel Returns, Confusion Over Coronavirus Vaccines Reigns

Fragmented rules about which vaccines will be accepted and what documentation is needed, as well as a lack of compatibility between vaccine apps, have left many travelers frustrated.

#biontech-se, #china-national-pharmaceutical-group-corp-sinopharm, #content-type-service, #european-medicines-agency, #mobile-applications, #travel-and-vacations, #travel-warnings, #vaccination-and-immunization, #vaccination-proof-and-immunization-records, #world-health-organization

Pfizer and BioNTech Submit Data on Vaccine for Kids 5 to 11

The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

States Begin a Complex Booster Shot Rollout for Pfizer Recipients

Health officials were preparing on Friday to start giving booster shots to older and at-risk Americans, trying to make sense of new and broad eligibility guidelines.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #food-and-drug-administration, #nursing-homes, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization, #walensky-rochelle

Federal Panel Recommends Booster Shots, Opening New Campaign Against the Virus

Scientific advisers to the C.D.C. endorsed additional doses of the Pfizer-BioNTech vaccine for older Americans but not for health care workers, in a possible rift with regulators.

#advisory-committee-on-immunization-practices, #biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #disease-rates, #elderly, #nursing-homes, #pfizer-inc, #preventive-medicine, #united-states-politics-and-government, #vaccination-and-immunization, #workplace-hazards-and-violations, #your-feed-science

Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge

A series of studies found that the Moderna vaccine seemed to be more protective over the long term than the Pfizer-BioNTech vaccine. Here’s why.

#biontech-se, #clinical-trials, #coronavirus-2019-ncov, #immune-system, #johnsonjohnson, #journal-of-the-american-medical-assn, #moderna-inc, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says

Vaccinated kids aged 5 to 11 showed evidence of protection against the virus, the company said. The data must be reviewed by the F.D.A. before children can be inoculated.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov, #disease-rates, #education-k-12, #masks, #moderna-inc, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

Are Covid Booster Shots Really Necessary?

As rich countries ponder the marginal utility of third doses, billions of people around the world are still waiting for their first.

#biden-joseph-r-jr, #biontech-se, #coronavirus-2019-ncov, #debatable, #moderna-inc, #pfizer-inc, #vaccination-and-immunization, #world-health-organization

Biden Falls Short on Pledge for U.S. to Be the World’s Vaccine ‘Arsenal,’ Experts Say

Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.

#american-rescue-plan-2021, #biden-joseph-r-jr, #biontech-se, #coronavirus-2019-ncov, #covax, #drugs-pharmaceuticals, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization